US bans imports from Chinese biotech company BGI and its affiliates over forced labor allegations
Summary
The Trump administration says it is blocking shipments from Chinese biotech company BGI and its affiliates, alleging ties to forced labor, The Philadelphia Inquirer and ABC News reported on Wednesday 28 October, headlining that the US bans imports from three Chinese biotech companies. The latest trade actions precede an expected meeting next month between Chinese leader Xi Jinping and U.S. President Donald Trump, Fortune reported on 29 October.
Latest: Fortune reported that the Trump administration's bar on imports from Chinese biotech companies it accuses of using forced labor precedes an expected meeting next month between Chinese leader Xi Jinping and U.S. President Donald Trump.
Written automatically by an AI from the articles' headlines and descriptions. It can contain errors: follow the links to read the articles.
How it unfolded
Thursday 29 October
Fortune reported that the Trump administration's bar on imports from Chinese biotech companies it accuses of using forced labor precedes an expected meeting next month between Chinese leader Xi Jinping and U.S. President Donald Trump.
Wednesday 28 October
The Trump administration says it is blocking shipments from Chinese biotech company BGI and its affiliates, alleging ties to forced labor, The Philadelphia Inquirer and ABC News reported.
- 18:47ABC News US bans imports from 3 Chinese biotech companies over forced labor allegations
- 18:41The Philadelphia Inquirer US bans imports from 3 Chinese biotech companies over forced labor allegations